Published in AIDS Weekly, November 20th, 1995
Adenoviral vectors are currently being used to deliver genes directly to patients as a form of in vivo gene therapy for such life threatening diseases as cystic fibrosis and cancer. The work was carried out by a team of scientists at Cell Genesys led by Mitchell Finer, Ph.D. and was reported at the Fourth International Conference on Gene Therapy of Cancer in San Diego, California.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.